Hantz Financial Services’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$231K	Sell	921 -16	-2%	-$3.98K	﹤0.01%	948
2025 Q4	$258K	Sell	937 -41	-4%	-$11.2K	﹤0.01%	771
2025 Q3	$256K	Sell	978 -69	-7%	-$16.8K	﹤0.01%	680
2025 Q2	$229K	Sell	1,047 -24,709	-96%	-$5.28M	﹤0.01%	601
2025 Q1	$5.77M	Sell	25,756 -1,061	-4%	-$292K	0.1%	192
2024 Q4	$8.78M	Buy	26,817 +490	+2%	+$154K	0.15%	145
2024 Q3	$7.9M	Sell	26,327 -2,739	-9%	-$839K	0.14%	173
2024 Q2	$9.57M	Sell	29,066 -1,287	-4%	-$455K	0.18%	139
2024 Q1	$12M	Sell	30,353 -2,160	-7%	-$799K	0.23%	114
2023 Q4	$11.4M	Sell	32,513 -1,240	-4%	-$439K	0.25%	118
2023 Q3	$12.7M	Sell	33,753 -20	-0.1%	-$7.73K	0.32%	88
2023 Q2	$12.9M	Buy	33,773 +851	+3%	+$304K	0.32%	85
2023 Q1	$11.4M	Sell	32,922 -1,403	-4%	-$410K	0.31%	88
2022 Q4	$8.08M	Sell	34,325 -2,473	-7%	-$586K	0.24%	130
2022 Q3	$9.05M	Buy	36,798 +1,161	+3%	+$354K	0.31%	97
2022 Q2	$10.8M	Buy	35,637 +524	+1%	+$171K	0.36%	80
2022 Q1	$14.4M	Buy	35,113 +2,136	+6%	+$836K	0.43%	59
2021 Q4	$15.5M	Buy	32,977 +2,082	+7%	+$896K	0.45%	60
2021 Q3	$13.1M	Buy	30,895 +3,766	+14%	+$1.59M	0.43%	66
2021 Q2	$9.74M	Buy	27,129 +1,372	+5%	+$453K	0.36%	75
2021 Q1	$7.26M	Buy	25,757 +1,393	+6%	+$399K	0.3%	92
2020 Q4	$6.9M	Buy	24,364 +641	+3%	+$180K	0.31%	93
2020 Q3	$6.52M	Buy	23,723 +541	+2%	+$143K	0.33%	80
2020 Q2	$5.27M	Buy	+23,182	New	+$4.55M	0.29%	101